Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors

Details for Australian Patent Application No. 2007316417 (hide)

Owner SuperGen, Inc.

Inventors Bearss, David J.; Liu, Xiao-Hui; Xu, Yong; Vankayalapati, Hariprasad

Agent Davies Collison Cave

Pub. Number AU-A-2007316417

PCT Pub. Number WO2008/058126

Priority 60/864,566 06.11.06 US; 60/957,988 24.08.07 US; 60/892,523 01.03.07 US

Filing date 6 November 2007

Wipo publication date 15 May 2008

International Classifications

A61K 31/5025 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

28 May 2009 PCT application entered the National Phase

  PCT publication WO2008/058126 Priority application(s): WO2008/058126

9 August 2012 Alteration of Name

  The name of the applicant has been altered to Astex Pharmaceuticals, Inc.

6 September 2012 Assignment before Grant

  Astex Pharmaceuticals, Inc. The application has been assigned to Tolero Pharmaceuticals, Inc. 2008

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007316418-Agonist TrkB antibodies and uses thereof

2007316416-Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs